Shikonin is a novel antagonist of prostaglandin E2 receptor 4 that targets myeloid-derived suppressor cells

Shikonin is a novel antagonist of prostaglandin E2 receptor 4 that targets myeloid-derived suppressor cells

Saved in:

Bibliographic Details
Main Authors:	Yang Wang, Naijipu Abuduaini, Wenjuan Liu, Yuanjun Song, Zunping Ke, Xilong Wang, Wei Jiao, Si Chen, Xianhua Lin, Weiwei Yu, Weiqiang Lu, Bo Feng, Jiacheng He
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2025-05-01
Series:	Genes and Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352304224001533
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effects of Shikonin on the Functions of Myeloid Dendritic Cells in a Mouse Model of Severe Aplastic Anemia
by: Mengying Zheng, et al.
Published: (2020-01-01)

N-Acetylcysteine enhances the action of anti-inflammatory drugs as suppressors of prostaglandin production in monocytes
by: Erica Hoffer, et al.
Published: (2002-01-01)

Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells.
by: Wenjuan Li, et al.
Published: (2014-01-01)

The role of myeloid-derived suppressor cells in children
by: Jordan Brauner, et al.
Published: (2025-02-01)

Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer
by: Hiroshi Katoh, et al.
Published: (2015-01-01)

Myeloid-derived suppressor cells and their role in gynecological malignancies
by: Seiji Mabuchi, et al.
Published: (2018-08-01)

Myeloid-Derived Suppressor Cells in Some Oncohematological Diseases
by: AV Ponomarev
Published: (2017-01-01)

MARCO expression on myeloid-derived suppressor cells is essential for their differentiation and immunosuppression
by: Sijia Liu, et al.
Published: (2025-07-01)

Inhibitory effects of a selective prostaglandin E2 receptor antagonist RQ-15986 on inflammation-related colon tumorigenesis in APC-mutant rats.
by: Yohei Shirakami, et al.
Published: (2021-01-01)

Circulating Monocytic Myeloid-Derived Suppressor Cells Are Elevated and Associated with Poor Prognosis in Acute Myeloid Leukemia
by: Huiping Wang, et al.
Published: (2020-01-01)

Myeloid-Derived Suppressor Cells in Bladder Cancer: An Emerging Target
by: Clément Klein, et al.
Published: (2024-10-01)

An oxidative stress mechanism of shikonin in human glioma cells.
by: Jen-Tsung Yang, et al.
Published: (2014-01-01)

Myeloid‐Derived Suppressor Cells in Cancer: Mechanistic Insights and Targeted Therapeutic Innovations
by: Tianying Hu, et al.
Published: (2025-06-01)

Myeloid-derived suppressor cells in secondary sepsis: Is there an association with lethal outcome?
by: Udovičić Ivo, et al.
Published: (2020-01-01)

Phenotypic and Functional Diversities of Myeloid-Derived Suppressor Cells in Autoimmune Diseases
by: Huijuan Ma, et al.
Published: (2018-01-01)

Optimization of the prostaglandin F2α receptor for structural biology.
by: Marine Salze, et al.
Published: (2025-01-01)

Shikonin inhibits NLRP3 inflammasome activation and controls inflammatory disease
by: Jing Huang, et al.
Published: (2025-05-01)

Th17/Treg balance is regulated by myeloid‐derived suppressor cells in experimental autoimmune myocarditis
by: Xin Xiong, et al.
Published: (2023-06-01)

Shikonin Induces Autophagy and Apoptosis in Esophageal Cancer EC9706 Cells by Regulating the AMPK/mTOR/ULK Axis
by: Junli Zhang, et al.
Published: (2024-01-01)

Myeloid-derived suppressor cells in axial spondyloarthritis patients with different types of therapy
by: A. Yu. Morenkova, et al.
Published: (2024-06-01)

Recruitment of Polymorphonuclear Myeloid-Derived Suppressor Cells During Cryptococcus neoformans Infection
by: JOYCE C. GUIMARÃES-DE-OLIVEIRA, et al.
Published: (2025-04-01)

The Role and Potential Therapeutic Application of Myeloid-Derived Suppressor Cells in Allo- and Autoimmunity
by: Qi Zhang, et al.
Published: (2015-01-01)

Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
by: Shuyan He, et al.
Published: (2025-01-01)

High Humidity Alters Myeloid-Derived Suppressor Cells in Spleen Tissue: Insights into Rheumatoid Arthritis Progression
by: Wang H, et al.
Published: (2024-11-01)

Correction: Shikonin inhibits NLRP3 inflammasome activation and controls inflammatory disease
by: Jing Huang, et al.
Published: (2025-08-01)

Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
by: Weiqiang Lu, et al.
Published: (2020-12-01)

Ultrasound-assisted preparation of shikonin-loaded emulsions for the treatment of bacterial infections
by: Xiaomiao Cui, et al.
Published: (2025-04-01)

Investigating the efficacy of mineralocorticoid receptor antagonists for cardiovascular outcomes in different diseases
by: Jiao Wang, et al.
Published: (2025-08-01)

Myeloid-Derived Suppressor Cells Show Different Frequencies in Diabetics and Subjects with Arterial Hypertension
by: Julio C. Fernández-Ruiz, et al.
Published: (2019-01-01)

Effect of pregnancy-specific β1-glycoprotein on myeloid-derived suppressor cell differentiation
by: V. P. Timganova, et al.
Published: (2023-06-01)

Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune Regulation
by: Irina Lyadova Vladimirovna, et al.
Published: (2016-01-01)

Galectin‐9 and myeloid‐derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia
by: Xierenguli Alimu, et al.
Published: (2023-05-01)

Interferon alpha-induced reduction in the values of myeloid-derived suppressor cells in melanoma patients
by: Stanojević Ivan, et al.
Published: (2015-01-01)

Targeting Myeloid-Derived Suppressor Cells via Dual-Antibody Fluorescent Nanodiamond Conjugate
by: Colin D. Angell, et al.
Published: (2024-09-01)

Role of the prostaglandin E2 EP1 receptor in traumatic brain injury.
by: Alexander V Glushakov, et al.
Published: (2014-01-01)

Tumor-intrinsic TTLL12 drives resistance to cancer immunotherapy via modulating myeloid-derived suppressor cells
by: Chong Chen, et al.
Published: (2025-06-01)

The predictive value of peripheral blood monocytic myeloid-derived suppressor cells for survival and immunotherapy responses in tumor patients
by: Wanying Sheng, et al.
Published: (2025-05-01)

A Novel CD48-Based Analysis of Sepsis-Induced Mouse Myeloid-Derived Suppressor Cell Compartments
by: Bei Jia, et al.
Published: (2017-01-01)

Depletion of myeloid-derived suppressor cells sensitizes murine multiple myeloma to PD-1 checkpoint inhibitors
by: Qiang Wang, et al.
Published: (2025-01-01)

Introduction of Leukotriene Receptor Antagonists in Manitoba
by: C Macie, et al.
Published: (2006-01-01)